Picture of BioXcel Therapeutics logo

BTAI BioXcel Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for BioXcel Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
fx
Preliminary
Cash and Equivalents
Cash and Short Term Investments32.4213233194
Net Total Accounts Receivable
Net Total Receivables0.248
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets34.1217237203
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment2.232.782.542.06
Other Long Term Assets
Total Assets36.4220239206
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities8.4711.816.732.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities9.513.217.8129
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity26.920722276.8
Total Liabilities & Shareholders' Equity36.4220239206
Total Common Shares Outstanding